精华制药(002349) - 2020 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2020 was ¥304,542,238.53, a decrease of 10.97% compared to ¥342,051,403.48 in the same period last year[9] - Net profit attributable to shareholders was ¥53,945,183.55, down 20.22% from ¥67,613,810.05 year-on-year[9] - Basic earnings per share decreased by 20.12% to ¥0.0663 from ¥0.0830 in the same period last year[9] - The company reported a decrease of 4.94% in net profit after deducting non-recurring gains and losses, amounting to ¥57,253,335.34 compared to ¥60,225,675.64 in the previous year[9] - Net profit decreased by 34.84% to ¥54,338,530.47 from ¥83,393,533.31, primarily due to a reduction in total profit[21] - The net profit for the current period is CNY 27,310,731.31, a decrease of 16.7% compared to CNY 32,757,236.25 in the previous period[68] - Operating profit for the current period is CNY 33,208,942.80, down from CNY 37,538,798.15, reflecting a decline of 11.0%[68] - The company reported a total comprehensive income of CNY 27,310,731.31, down from CNY 32,757,236.25, indicating a decrease of 16.7%[71] Cash Flow - The net cash flow from operating activities increased significantly by 616.48%, reaching ¥48,197,106.08 compared to ¥6,726,974.68 in the previous year[9] - Cash received from investment increased by 937.44% to ¥23,211,200.00 from ¥2,237,346.63, attributed to the sale of equity by a subsidiary[21] - Cash received from investment income surged by 2655.92% to ¥21,610,703.80 from ¥784,155.44, due to dividend distributions from a subsidiary[21] - Cash received from other operating activities increased by 94.33% to ¥13,321,216.32 from ¥6,854,938.84, reflecting an increase in other cash receipts[24] - Cash flow from operating activities increased to CNY 285,148,205.08, compared to CNY 253,135,776.32 in the previous period, representing a growth of 12.6%[72] - The net cash flow from investing activities is CNY 15,765,985.31, a significant improvement from a negative CNY 34,705,954.80 in the previous period[75] - The company reported a net decrease in cash and cash equivalents of $31,786,344.39, contrasting with an increase of $44,336,318.10 in the previous period[83] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,942,040,439.82, a slight increase of 0.02% from ¥2,941,338,590.70 at the end of the previous year[9] - Net assets attributable to shareholders increased by 2.99% to ¥1,905,163,886.92 from ¥1,849,906,867.35 at the end of the previous year[9] - Total non-current assets amounted to approximately $1.85 billion, a slight increase from $1.84 billion, indicating a growth of 0.7%[40] - Current liabilities decreased to approximately $549 million, down from $554 million, a reduction of 0.6%[43] - Total liabilities decreased to approximately $738 million from $793 million, a decline of 6.9%[43] - Total equity increased to approximately $2.20 billion, up from $2.15 billion, reflecting a growth of 2.4%[46] Shareholder Information - The top shareholder, Nantong Industrial Holdings Group Co., Ltd., holds 34.29% of the shares, totaling 286,592,160 shares[14] - The total number of ordinary shareholders at the end of the reporting period was 47,763[14] Expenses - Total operating costs decreased to ¥238,064,393.99 from ¥254,836,558.80, reflecting a reduction of 6.63%[58] - Research and development expenses increased to ¥9,899,701.65 from ¥8,027,276.11, representing a growth of 23.38%[58] - The company incurred a total operating expense of CNY 236,951,099.00, slightly lower than CNY 246,408,801.64 in the previous period, reflecting a decrease of 3.0%[75] Other Financial Metrics - Investment income for the current period is ¥2,670,961.73, down from ¥4,006,087.12, a decline of 33.24%[58] - Other income decreased to ¥441,208.68 from ¥1,322,682.21, a decline of 66.66%[58] - Interest expenses increased by 89.67% to ¥6,291,470.15 from ¥3,317,080.89, primarily due to higher capitalized interest from a subsidiary[21] Future Plans - The company plans to expand its market presence and invest in new product development to drive future growth[74] Miscellaneous - The company did not engage in any repurchase transactions during the reporting period[18] - The company did not apply the new revenue and leasing standards for the first quarter of 2020[84] - The first quarter report was not audited[86]